Let's start out in Israel. We've talked about them quite a bit. They had the most aggressive

vaccine push really in the world. That started in late December. And I'm saying that, some

framing some new information that's coming forward. This is from a professor at MIT Sloan

School of Management. His name is Retsif Levy. He specializes in data analytics,

guiding health and healthcare decisions. And what he did is he looked at what's called the

McGon-Davad-Adam. That's MDA. This is Israel's National Emergency Services and Ambulatory Services.

He looked at all the data they had on calls for what's called a cute coronary syndrome.

And he came up with this chart after collating the data. It's very interesting. So we have a

highlight here. And for people just listening, you can see it's broken up in a male and female

and the age groups. So we have the age group of 16 to 19. What they did was they compared 2019

January 1st to May 31st, 2019 to January 1st to May 31st, 2021. And what they found was the calls

to this ambulatory service emergency care for a cute coronary syndrome in males 16 to 19 saw a 91.7

percent increase. Males 20 to 29 saw a 31.1 percent increase. Then we got out into females 16 to

19 age groups. So 140 percent increase, their females 20 to 29 percent saw an 83.6 percent increase.

So an incredible increase. I mean, every one of those values, we see over 50 percent increase

pretty much except for a couple. And so what he did was he forwarded this information urgently

to the Ministry of Health in Israel twice and had no answer. Why is this important? Because a cute

coronary syndrome in the scientific literature, there's tons of scientific literature saying that

that syndrome is almost identical to myocarditis, paracarditis, and is very hard to determine

the difference between the two because they present with the same symptoms like head and his

dizziness, fainting, abnormal heartbeat, breathing difficulties. So that's setting up what we're

going to go into. And now let's look at VAERS. So we have open VAERS data here. And we have a

...